These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 32320652)
1. Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1. Sanchez-Martin C; Moroni E; Ferraro M; Laquatra C; Cannino G; Masgras I; Negro A; Quadrelli P; Rasola A; Colombo G Cell Rep; 2020 Apr; 31(3):107531. PubMed ID: 32320652 [TBL] [Abstract][Full Text] [Related]
2. Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1. Sanchez-Martin C; Menon D; Moroni E; Ferraro M; Masgras I; Elsey J; Arbiser JL; Colombo G; Rasola A Antioxid Redox Signal; 2021 Mar; 34(7):505-516. PubMed ID: 32438819 [No Abstract] [Full Text] [Related]
3. Protein Allostery and Ligand Design: Computational Design Meets Experiments to Discover Novel Chemical Probes. Triveri A; Sanchez-Martin C; Torielli L; Serapian SA; Marchetti F; D'Acerno G; Pirota V; Castelli M; Moroni E; Ferraro M; Quadrelli P; Rasola A; Colombo G J Mol Biol; 2022 Sep; 434(17):167468. PubMed ID: 35101454 [TBL] [Abstract][Full Text] [Related]
4. Dynamics-based community analysis and perturbation response scanning of allosteric interaction networks in the TRAP1 chaperone structures dissect molecular linkage between conformational asymmetry and sequential ATP hydrolysis. Verkhivker GM Biochim Biophys Acta Proteins Proteom; 2018 Aug; 1866(8):899-912. PubMed ID: 29684503 [TBL] [Abstract][Full Text] [Related]
5. Dual Binding to Orthosteric and Allosteric Sites Enhances the Anticancer Activity of a TRAP1-Targeting Drug. Hu S; Ferraro M; Thomas AP; Chung JM; Yoon NG; Seol JH; Kim S; Kim HU; An MY; Ok H; Jung HS; Ryu JH; Colombo G; Kang BH J Med Chem; 2020 Mar; 63(6):2930-2940. PubMed ID: 32068404 [TBL] [Abstract][Full Text] [Related]
6. HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia. Laquatra C; Sanchez-Martin C; Dinarello A; Cannino G; Minervini G; Moroni E; Schiavone M; Tosatto S; Argenton F; Colombo G; Bernardi P; Masgras I; Rasola A Cell Death Dis; 2021 May; 12(5):434. PubMed ID: 33934112 [TBL] [Abstract][Full Text] [Related]
10. The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis. Joshi A; Dai L; Liu Y; Lee J; Ghahhari NM; Segala G; Beebe K; Jenkins LM; Lyons GC; Bernasconi L; Tsai FTF; Agard DA; Neckers L; Picard D BMC Biol; 2020 Jan; 18(1):10. PubMed ID: 31987035 [TBL] [Abstract][Full Text] [Related]
11. Paralog Specificity Determines Subcellular Distribution, Action Mechanism, and Anticancer Activity of TRAP1 Inhibitors. Park HK; Jeong H; Ko E; Lee G; Lee JE; Lee SK; Lee AJ; Im JY; Hu S; Kim SH; Lee JH; Lee C; Kang S; Kang BH J Med Chem; 2017 Sep; 60(17):7569-7578. PubMed ID: 28816449 [TBL] [Abstract][Full Text] [Related]
12. Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1. Lee C; Park HK; Jeong H; Lim J; Lee AJ; Cheon KY; Kim CS; Thomas AP; Bae B; Kim ND; Kim SH; Suh PG; Ryu JH; Kang BH J Am Chem Soc; 2015 Apr; 137(13):4358-67. PubMed ID: 25785725 [TBL] [Abstract][Full Text] [Related]
13. Mitoquinone Inactivates Mitochondrial Chaperone TRAP1 by Blocking the Client Binding Site. Yoon NG; Lee H; Kim SY; Hu S; Kim D; Yang S; Hong KB; Lee JH; Kang S; Kim BG; Myung K; Lee C; Kang BH J Am Chem Soc; 2021 Dec; 143(47):19684-19696. PubMed ID: 34758612 [TBL] [Abstract][Full Text] [Related]
14. New insights into molecular chaperone TRAP1 as a feasible target for future cancer treatments. Li XT; Li YS; Shi ZY; Guo XL Life Sci; 2020 Aug; 254():117737. PubMed ID: 32376268 [TBL] [Abstract][Full Text] [Related]
15. Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1. Masgras I; Ciscato F; Brunati AM; Tibaldi E; Indraccolo S; Curtarello M; Chiara F; Cannino G; Papaleo E; Lambrughi M; Guzzo G; Gambalunga A; Pizzi M; Guzzardo V; Rugge M; Vuljan SE; Calabrese F; Bernardi P; Rasola A Cell Rep; 2017 Jan; 18(3):659-672. PubMed ID: 28099845 [TBL] [Abstract][Full Text] [Related]
16. Dissecting Molecular Principles of the Hsp90 Chaperone Regulation by Allosteric Modulators Using a Hierarchical Simulation Approach and Network Modeling of Allosteric Interactions: Conformational Selection Dictates the Diversity of Protein Responses and Ligand-Specific Functional Mechanisms. Astl L; Stetz G; Verkhivker GM J Chem Theory Comput; 2020 Oct; 16(10):6656-6677. PubMed ID: 32941034 [TBL] [Abstract][Full Text] [Related]
17. Development of pyrazolo[3,4-d]pyrimidine-6-amine-based TRAP1 inhibitors that demonstrate in vivo anticancer activity in mouse xenograft models. Kim D; Kim SY; Kim D; Yoon NG; Yun J; Hong KB; Lee C; Lee JH; Kang BH; Kang S Bioorg Chem; 2020 Aug; 101():103901. PubMed ID: 32590225 [TBL] [Abstract][Full Text] [Related]
18. Allosteric Regulation Points Control the Conformational Dynamics of the Molecular Chaperone Hsp90. Rehn A; Moroni E; Zierer BK; Tippel F; Morra G; John C; Richter K; Colombo G; Buchner J J Mol Biol; 2016 Nov; 428(22):4559-4571. PubMed ID: 27663270 [TBL] [Abstract][Full Text] [Related]
19. 2.4 Å resolution crystal structure of human TRAP1NM, the Hsp90 paralog in the mitochondrial matrix. Sung N; Lee J; Kim JH; Chang C; Tsai FT; Lee S Acta Crystallogr D Struct Biol; 2016 Aug; 72(Pt 8):904-11. PubMed ID: 27487821 [TBL] [Abstract][Full Text] [Related]
20. TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors. Kang BH BMB Rep; 2012 Jan; 45(1):1-6. PubMed ID: 22281005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]